South San Francisco, California -- Biotechnology company Fluidigm has secured $5 million in new venture capital debt, according to an SEC regulatory filing.Fluidigm sells integrated fluidic circuits, consumables, instrumentation and other technologies to the scientific industry.Investors in the new financing were not disclosed, nor was how the company intends to use the funding proceeds.